Carrie Ann Inaba to return as DWTS judge amid Sjogren Syndrome battle meaww.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from meaww.com Daily Mail and Mail on Sunday newspapers.
Wize Pharma set for switch to Bitcoin mining
Wize Pharma has spun off its ophthalmology drug development activities, and will begin to mine digital currencies in another month through Cosmos.
Wize Pharma (OTCQB: WIZP), from Hod Hasharon, has reported that it has met all the preconditions for implementing the offer to purchase the shares of Australian bitcoin miner Cosmos Capital Ltd. Wize Pharma expects to complete the purchase of the shares by March 9, 2021. One of the conditions was that the level of response should be a minimum of 90% of Cosmos shareholders, and as of yesterday a response had been received (including a commitment to respond) of Cosmos shareholders, holding about 94.5% of the company s equity.
Wize Pharma merges with Australian Bitcoin miner Cosmos
The Israeli biopharmaceutical company will spin off its drug development activity and focus on Bitcoin mining.
Israeli clinical stage biopharmaceutical company Wize Pharma Inc. (OTCQB: WIZP) will merge with privately-held Australian digital currency infrastructure provider Cosmos Capital, in an all share deal, which will ultimately leave Cosmos s shareholders owning most of Wize s shares. Wize, which is controlled by Rimon Gold, the investment arm of serial entrepreneur Yair Goldfinger, US investor Jonathan Rubini, and its CEO Noam Danenberg, will spin off its ophthalmic disorders drug development activities.
Cosmos, which was founded 18 months ago, mainly specializes in mining Bitcoin as well as providing a digital infrastructure, which aims to act as a bridge between the growing digital currency industry and traditional capital markets. Mining Bitcoin is a process of verifying transactions in digital currencies through the